Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

4.3%

1 terminated/withdrawn out of 23 trials

Success Rate

93.8%

+7.2% vs industry average

Late-Stage Pipeline

13%

3 trials in Phase 3/4

Results Transparency

0%

0 of 15 completed trials have results

Key Signals

Enrollment Performance

Analytics

Phase 1
16(69.6%)
Phase 2
4(17.4%)
Phase 3
3(13.0%)
23Total
Phase 1(16)
Phase 2(4)
Phase 3(3)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (23)

Showing 20 of 23 trials
NCT04539496Phase 1Active Not Recruiting

A Phase I/II Study of XZP-3287 in Metastasis Solid Tumors

Role: lead

NCT04622072Phase 1Terminated

XZP-5809-TT1 Tablets in Patients With T790M Mutation-positive Locally Advanced or Metastatic Non-small Cell Lung Cancer

Role: lead

NCT02442414Phase 1Completed

A Phase 1 Study of KBP-5209 in Patients With Advanced Solid Tumors

Role: lead

NCT04505683Phase 2Completed

A Study to Assess Efficacy and Safety Intravenous Benapenem in Patients With Complicated Urinary Tract Infection (cUTI) or Acute Pyelonephritis (AP)

Role: lead

NCT04503629Phase 2Completed

A Phase 2 Randomised Controlled Trial to Evaluate Efficacy and Safety of Anaprazole in Patients With Duodenal Ulcers.

Role: lead

NCT04476394Phase 1Unknown

Open-label Study to Assess the Absorption, Metabolism, Excretion, and Mass Balance of a Single Oral Dose of [14C]-20 mg/100 μCi Anaprazole Sodium Enteric-coated Capsule in Healthy Adult Male Subjects

Role: lead

NCT04476407Phase 1Completed

Pharmacokinetics of Benapenem in Subjects With Renal Impairment

Role: lead

NCT03811548Phase 3Unknown

Janagliflozin Treat T2DM Monotherapy

Role: lead

NCT03851432Phase 3Unknown

Janagliflozin Treat Type 2 Diabetes Mellitus (T2DM) Inadequately Controlled With Metformin

Role: lead

NCT04471922Phase 1Completed

A Multiple Ascending High Dose Pharmacology Study of Anaprazole in Healthy Chinese Subjects

Role: lead

NCT04467060Phase 1Completed

A Single Ascending Dose Pharmacology Study of Anaprazole in Healthy Chinese Subjects

Role: lead

NCT04467203Phase 1Completed

Evaluate the Effects of Food on the Pharmacokinetics of Fadanafil in Healthy Subjects

Role: lead

NCT04466748Phase 1Completed

A Multiple Ascending Dose Pharmacology Study of Anaprazole in Healthy Chinese Subjects

Role: lead

NCT04463173Phase 1Completed

Food Effect Study of Anaprazole in Healthy Chinese Subjects

Role: lead

NCT04444011Phase 1Unknown

Pharmacokinetic Interactions of Quadruple Therapy With Anaprazole/Amoxicilin/Clarithromycin/Bismuth

Role: lead

NCT04312568Phase 1Completed

Evaluate Safety, Tolerability and Pharmacokinetics of Fadanafil (XZP-5849)in Chinese Healthy Adult Male Subjects

Role: lead

NCT04215653Phase 3Unknown

A Phase 3 Randomised Controlled Trial to Evaluate Efficacy and Safety of Anaprazole in Patients With Duodenal Ulcers.

Role: lead

NCT04200261Phase 1Unknown

Multiple-dose Tolerability and Pharmacokinetic Studies of Benapenem in Clinical Healthy Subjects

Role: lead

NCT03588156Phase 1Completed

Single-dose PK Study of Benapenem In Healthy Subjects

Role: lead

NCT03578588Phase 1Completed

Benapenem PK Phase Ib Multiple-dose Study

Role: lead